XML 55 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash flows from operating activities:    
Net loss $ (26,041) $ (6,470)
Adjustments to reconcile net loss to net cash flows provided by operating activities:    
Asset retirement obligations accretion expense 3,744 3,763
Depreciation, depletion and amortization 86,439 81,127
Equity-based compensation cost 13,080 12,390
Impairment of oil and natural gas properties 8,141 17,752
Noncash derivative activity 26,162 39,395
Equity in (income) losses of unconsolidated affiliates (237) 60
Distribution from unconsolidated affiliates 171  
Other 2,313 4,698
Changes in operating assets and liabilities:    
Accounts receivable (6,430) 3,138
Other current assets (5,435) 656
Accounts payable and accrued liabilities 17,889 20,479
Other, net (561) (1,955)
Net cash flows provided by operating activities 119,235 175,033
Cash flows from investing activities:    
Acquisitions of oil and natural gas properties   (118,925)
Final settlement of purchase price of oil and natural gas properties 7,998  
Additions to oil and natural gas properties (75,799) (100,392)
Proceeds from sale of oil and natural gas properties   5,522
Investments in unconsolidated affiliates (172,003) (18,998)
Distributions from unconsolidated affiliates 33  
Settlements from acquired derivatives   4,166
Net cash flows used in investing activities (239,771) (228,627)
Cash flows from financing activities:    
Long-term debt borrowings 225,000 120,000
Repayment of long-term debt borrowings   (460,000)
Proceeds from debt offering   206,000
Loan costs incurred   (4,152)
Proceeds from public equity offering   262,833
Offering costs   (304)
Contributions from general partner 334 5,714
Distributions paid (101,646) (95,845)
Net cash flows provided by financing activities 123,688 34,246
Increase (decrease) in cash and cash equivalents 3,152 (19,348)
Cash and cash equivalents - beginning of period 7,486 30,312
Cash and cash equivalents - end of period $ 10,638 $ 10,964